News Headlines Article

F.D.A. Clears Way for Embryonic Stem Cell Trial Using Patients
New York Times

The world’s first authorized test in people of a treatment derived from human embryonic stem cells has been cleared to begin by the Food and Drug Administration.

The trial will test cells developed by Geron Corporation and the University of California, Irvine in patients with new spinal cord injuries.